Overview
Lobbying Costs
1,750,000€
Financial year: Jan 2014 - Dec 2014
Lobbyists (Full time equivalent)
5 Fte (11)
Lobbyists with EP accreditation
8
High-level Commission meetings
12
Lobbying Costs over the years
-
Info
GlaxoSmithKline (GSK)
EU Transparency Register
7990322925-77 First registered on 06 Jan 2009
Goals / Remit
GSK is a science-led global healthcare company.
Our mission is to help people do more, feel better, live longer.
We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare that can improve people’s health and well-being, ultimately helping them to live life to its fullest and contribute to the prosperity of their communities.
Our Pharmaceuticals business develops and makes medicines to treat a broad range of acute and chronic diseases. Our portfolio is made up of both patent-protected and off patent medicines and we have leading global positions in respiratory disease and HIV.
Our Vaccines business is one of the largest in the world. We have a broad portfolio of over 30 paediatric, adolescent, adult and travel vaccines. In 2014, we distributed approximately 800 million doses in 170 countries.
We develop and market a range of consumer healthcare products based on scientific innovation. We have brands in four main categories: Wellness, Oral Health, Skin Health and Nutrition. These include a number of well-known brands such as Sensodyne, Panadol and Horlicks.
We have a significant global presence with commercial operations in more than 150 countries, a network of 84 manufacturing sites in 36 countries and large R&D centres in the UK, USA, Spain, Belgium and China.Main EU files targeted
We follow EU initiatives, policies and legislative files related to our Pharmaceuticals, Vaccines and Consumer Healthcare businesses.
This includes topics such as R&D and clinical trials, antimicrobial resistance, data protection, pharmaceutical legislation, medical devices, trade & IP, environment, smoking cessation.Address
Head Office
Great West Road, 980
Brentford, Middlesex TW8 9GS
UNITED KINGDOMEU Office
Avenue des Arts 46/b9
Brussels 1000
BELGIUM -
People
Total lobbyists declared
11
Employment time Lobbyists 75% 3 50% 3 25% 5 Lobbyists (Full time equivalent)
5
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
8 accreditations were / are live (in bold) for the selected state of 27 Apr 2015
Name Start date End Date Sofia BENITO KWIECINSKI 20 Feb 2024 19 Feb 2025 Bonifac Abel MAKKAI 20 Mar 2024 02 Oct 2024 Alberto GIUMMARRA 12 Mar 2024 11 Mar 2025 Gisela PAYERAS BAILLY 20 Mar 2024 02 Oct 2024 Alberto GIUMMARRA 18 Mar 2023 12 Mar 2024 Ms Renatte Georgescu 17 Mar 2023 16 Mar 2024 Sofia BENITO KWIECINSKI 22 Feb 2023 20 Feb 2024 Ms Chloe CROSS 02 Aug 2022 02 Aug 2023 Gisela PAYERAS BAILLY 09 Apr 2022 08 Apr 2023 Alberto GIUMMARRA 01 Apr 2022 18 Mar 2023 Ms Renatte Georgescu 01 Apr 2022 17 Mar 2023 Ms Chloe CROSS 15 Apr 2021 15 Apr 2022 Gisela PAYERAS BAILLY 15 Apr 2021 09 Apr 2022 Alberto GIUMMARRA 07 Apr 2021 01 Apr 2022 Ms Renatte Georgescu 07 Apr 2021 01 Apr 2022 Mihaela ALIONTE 22 Feb 2020 20 Feb 2021 Alberto GIUMMARRA 22 Feb 2020 20 Feb 2021 Ms Renatte Georgescu 08 Feb 2020 06 Feb 2021 Ms Katja Murray 25 Jan 2020 01 Feb 2021 Valentina Laurenzia Ancona 25 Jan 2020 01 Feb 2021 Gisela PAYERAS BAILLY 08 Nov 2019 07 Nov 2020 Ms Georgia Catherine JANE CASSARINO 17 Oct 2019 17 Oct 2020 Mr Guilherme Monteiro Ferreira Borges Dos Santos 05 Sep 2019 05 Sep 2020 Christian BARACAT 05 Sep 2019 18 Oct 2019 Mr Paulus Lambertus Antonius van Hoof 17 Aug 2019 15 Aug 2020 Ms Renatte Georgescu 02 Feb 2019 08 Feb 2020 Gisela PAYERAS BAILLY 31 Oct 2018 31 Oct 2019 Ms Georgia Catherine JANE CASSARINO 26 Oct 2018 17 Oct 2019 Christian BARACAT 05 Sep 2018 05 Sep 2019 Mr Paulus Lambertus Antonius van Hoof 07 Aug 2018 07 Aug 2019 Mr Guilherme Monteiro Ferreira Borges Dos Santos 19 Jun 2018 19 Jun 2019 Gisela PAYERAS BAILLY 27 Oct 2017 26 Oct 2018 Ms Georgia Catherine JANE CASSARINO 27 Oct 2017 25 Oct 2018 Christian BARACAT 31 Aug 2017 17 Aug 2018 Mr Paulus Lambertus Antonius van Hoof 31 Aug 2017 07 Aug 2018 Mr Guilherme Monteiro Ferreira Borges Dos Santos 10 Oct 2016 07 Oct 2017 Gisela PAYERAS BAILLY 05 Sep 2016 31 Aug 2017 Christian BARACAT 22 Aug 2016 02 Aug 2017 Mr Paulus Lambertus Antonius van Hoof 22 Aug 2016 02 Aug 2017 Mr Guilherme Monteiro Ferreira Borges Dos Santos 26 Sep 2015 25 Sep 2016 Ms Karin Jeanette Drielsma 22 Sep 2015 31 Jan 2016 Christian BARACAT 29 Aug 2015 23 Aug 2016 Gisela PAYERAS BAILLY 29 Aug 2015 28 Aug 2016 Mr Paulus Lambertus Antonius van Hoof 31 Jul 2015 29 Jul 2016 Ms Karin Jeanette Drielsma 06 Aug 2014 04 Aug 2015 Ms Sophie Renee Jeanne Marie Philippine Crousse 03 Sep 2014 28 Aug 2015 Gisela PAYERAS BAILLY 26 Aug 2014 19 Aug 2015 Mr Nicholas Collinge Crosby 08 Oct 2014 03 Jun 2015 Ms Diana Mereu 04 Oct 2014 03 Jun 2015 Mr Guilherme Monteiro Ferreira Borges Dos Santos 30 Sep 2014 26 Sep 2015 Mrs Sophie Renee Jeanne Marie Philippine Crousse 03 Sep 2014 27 Jan 2015 Christian BARACAT 26 Aug 2014 19 Aug 2015 Gisela PAYERAS BAILLY 26 Aug 2014 27 Jan 2015 Mrs Karin Jeanette Drielsma 06 Aug 2014 27 Jan 2015 Mr Paulus Lambertus Antonius van Hoof 02 Aug 2014 31 Jul 2015 Mr Guilherme Monteiro Ferreira Borges Dos Santos 28 Sep 2013 27 Sep 2014 Mrs Elisaveta Voynova 28 Sep 2013 27 Sep 2014 Mr Paulus Lambertus Antonius van Hoof 25 Jul 2013 24 Jul 2014 Gisela PAYERAS BAILLY 25 Jul 2013 24 Jul 2014 Mr Christopher Black 23 Jul 2013 20 Jul 2014 Mr Johan Christoffer Thor 23 Jul 2013 20 Jul 2014 Mrs Karin Jeanette Drielsma 23 Jul 2013 20 Jul 2014 Mrs Sophie Renee Jeanne Marie Philippine Crousse 23 Jul 2013 20 Jul 2014 Mr Philippe GHYSSELS 17 Jan 2012 08 Feb 2013 Complementary Information
The number of persons reflects the full time employment falling under the scope of the register. GSK follows the guidelines provided by EFPIA regarding this registration.
Person in charge of EU relations
Ms Sue Middleton (Vice President European Government Affairs)
Person with legal responsibility
Mr Andrew Witty (Chief Executive Officer)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
American Chamber of Commerce to the European Union (AmChamEU)
Association of the European Self-Medication Industry (AESGP)
British Chamber of Commerce in Belgium
Cosmetics Europe
EuropaBio
European Biopharmaceutical Enterprises (EBE)
European Brands Association (AIM)
European Diagnostic Manufacturers Association (EDMA)
European Federation of Pharmaceutical Industries and Associations (EFPIA)
Vaccines Europe (VE)
World Federation of Advertisers (WFA)Member organisations
None declared
-
Financial Data
Closed financial year
Jan 2014 - Dec 2014
Lobbying costs for closed financial year
1,750,000€
EU grant income for closed financial year
10,445,466 € (Source: FP7-People; FP7-NMP; Horizon 2020)
Other financial info
In 2013, GSK’s estimated costs attributable to activities covered by the Register were in the range of 600.000-700.000. While GSK maintained activities in scope of the register from 2013 to 2014, the increased figures result from vacancies and the renewed “transparency register implementing guidelines” published 21 January 2015 by the Joint Transparency Register Secretariat.
GSK followed EFPIA’s interpretation and guidance on implementing those guidelines in 2014. -
EU Structures
Groups (European Commission)
EC Expert Group on Rare-Diseases (on behalf of EuropaBio)
ACC
None
Groups (European Parliament)
None
Communication activities
Mainly via the participation of events organized by Trade Associations and Think-Tanks.
Other activities
None declared
- Meetings
Meetings
12 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 28 Apr 2021 Location Brussels Subject EU vaccine production and pandemic preparedness Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Maurits-Jan Prinz (Cabinet member)
-
Date 11 Feb 2021 Location webex Subject vaccines DG Health and Food Safety Attending - Sandra Gallina (Director-General)
-
Date 31 May 2018 Location Brussels Subject Brexit preparedness Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
-
Date 23 Mar 2018 Location Brussels Subject IP regime generic manufacturers in the pharmaceutical industry Cabinet Cabinet of Commissioner Pierre Moscovici Portfolio Economic and Financial Affairs, Taxation and Customs Attending - Leila Fernandez-Stembridge (Cabinet member)
-
Date 01 Dec 2017 Location Brussels Subject FTA implementation & transparency / trade relations with China, Turkey, Russia / importance of including vaccines in trade negotiations Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Maria Asenius (Cabinet member)
- Nele Eichhorn (Cabinet member)
-
Date 09 Nov 2017 Location Brussels Subject Innovation in the pharmaceutical sector, SPC, health technology assessments Cabinet Cabinet of Vice-President Jyrki Katainen Portfolio Jobs, Growth, Investment and Competitiveness Attending - Marika Lautso-Mousnier (Cabinet member)
-
Date 26 Jun 2017 Location Brussels Subject Antimicrobial resistance (AMR) Cabinet Cabinet of Commissioner Carlos Moedas Portfolio Research, Science and Innovation Attending - Carlos Moedas (Commissioner)
-
Date 30 Sep 2015 Location Brussels Subject Vaccination Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Paula Duarte Gaspar (Cabinet member)
-
Date 24 Sep 2015 Location Brussels Subject Challenges of the pharma industry Cabinet Cabinet of Commissioner Carlos Moedas Portfolio Research, Science and Innovation Attending - Carlos Moedas (Commissioner)
-
Date 18 May 2015 Location Brussels Subject Access to medicines in Africa Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Cécile Billaux (Cabinet member)
-
Date 16 Jan 2015 Location PRAGUE, CZECH REPUBLIC Subject Round Table on Gender Diversity Cabinet Cabinet of Commissioner Věra Jourová Portfolio Justice, Consumers and Gender Equality Attending - Věra Jourová (Commissioner)
Other Lobbyists -
Date 05 Dec 2014 Location Brussels Subject Life sciences contribution to growth and jobs Cabinet Cabinet of Vice-President Jyrki Katainen Portfolio Jobs, Growth, Investment and Competitiveness Attending - Aura Salla (Cabinet member)
- Heidi Jern (Cabinet member)
- Meetings